We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.71M | -11.11M | -0.0441 | -2.72 | 30.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2024 16:52 | Could not get link to work - but point noted so patience required before any thoughts of US move...a small amount of buying interest today which makes a change. | takeiteasy | |
22/2/2024 10:07 | Agreed - I see this as a 2-3 year view for a smallish holding for me...just like their approach and they seem more proactive than many of the other biotecs dyor etc | takeiteasy | |
22/2/2024 10:05 | Valued at cash according to my calculations so adding below 11 to complement my PRTC holding. Biotechs valued at cash with a development pipeline should rerate over time, patience required | rimau1 | |
21/2/2024 17:40 | https://x.com/ruth_p | bloomberg2 | |
21/2/2024 14:18 | This sector goes in and out of favour. At this present time its out. Seen so many cycles like this. The most important thing in these down period is to have cash. It has enough for the nxt 18-24 mths - the likelihood of positive news flow over this period is high. Total value of trades today is £32k, which implies punters getting bored. | smithless | |
21/2/2024 13:15 | this stock has no friends at all - does it? I repeat imvho there is no point in a stock like this being in the UK and a move to Nasdaq is surely essential soon. UK market does not seem to understand loss making small cap biotechs - or does not have time for them except in one or two specialist funds.... dyor etc | takeiteasy | |
15/2/2024 13:30 | You sure ? hahaha | gahi23 | |
14/2/2024 21:38 | they have a couple of years cash, so no placing soon. | davemac3 | |
14/2/2024 07:57 | What about the 800 million in free cash injections over the coming years?. You can't take that away from us. | luckyabbeygale | |
14/2/2024 07:00 | Gah - are you trying to wake this up from perma sleep mode ...nice try. Give the patient some caffeine pills maybe... | takeiteasy | |
14/2/2024 06:23 | Below 10p next week you suckers hahaha | gahi23 | |
14/2/2024 06:23 | Changed my mind ! Selling on the bell today been told a placing soon lol | gahi23 | |
12/2/2024 21:04 | Yes, expect a strong move soon. | gah123 | |
12/2/2024 20:52 | Nasdaq biotech small caps moving up again it seems - may feed over at some stage. Dyor etc | takeiteasy | |
07/2/2024 13:43 | Bargain hunters out | bloomberg2 | |
06/2/2024 20:10 | Was watching today to see if the 50dsma would hold again. It did all day but end of day this was the last stock to close on my monitor and ended down that half pence on an 8 share trade. Looked rather contrived? | bad gateway | |
06/2/2024 18:19 | Lesson of owning FUM today is that you can never time these tiddlers, you need to be comfortable sitting and waiting - hopefully only a few months in this case for some further action. dyor etc | takeiteasy | |
05/2/2024 16:21 | Starting to look cheap here after the news spike. Chance to have a read up and refresh the old brain cells on whats happening here tonight I think. | bad gateway | |
03/2/2024 17:46 | Further milestone would be good deffo - I still think they additionally need to diversify routes to market with their IP - there must be multiple use cases to explore surely now they are building up expertise working with the big boys | takeiteasy | |
03/2/2024 17:12 | Sanofi 2nd milestone should be due relatively soon. That would definitely start the thrusters | hatfullofsky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions